Patents by Inventor Steven R. Byrn

Steven R. Byrn has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NADH oxidase assay for neoplasia determination
    Patent number: 5605810
    Abstract: NADH oxidase is shown to be a target for a variety of uses in diagnosis and therapy. Particularly, the NADH oxidase associated with neoplastic cells is immunologically and biologically different from NADH oxidase associated with normal cells. Thus, the presence of tumor cells in patients can be monitored by monitoring the NADH oxidase of serum. In addition, use of the NADH oxidase associated with tumor cells provides opportunities for assays for screening drugs which are specific for neoplastic cells and can serve as anticancer drugs or growth inhibitors.
    Type: Grant
    Filed: April 5, 1994
    Date of Patent: February 25, 1997
    Assignee: Purdue Research Foundation
    Inventors: D. James Morr e, Steven R. Byrn, Frederick L. Crane, Dorothy M. Morr e